In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 1.65 million shares changing hands with its beta currently measuring 0.67. Company’s recent per share price level of $0.96 trading at -$0.04 or -4.31% at ring of the bell on the day assigns it a market valuation of $176.51M. That closing price of NKTR’s stock is at a discount of -101.04% from its 52-week high price of $1.93 and is indicating a premium of 34.37% from its 52-week low price of $0.63.

For Nektar Therapeutics (NKTR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.33. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Nektar Therapeutics (NASDAQ:NKTR) trade information

Upright in the red during last session for losing -4.31%, in the last five days NKTR remained trading in the green while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $0.96 price level, adding 11.11% to its value on the day. Nektar Therapeutics’s shares saw a change of 2.89% in year-to-date performance and have moved 30.90% in past 5-day. Nektar Therapeutics (NASDAQ:NKTR) showed a performance of 5.85% in past 30-days.

Wall Street analysts have assigned a consensus price target of 18.5 to the stock, which implies a rise of 94.81% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 24. It follows that stock’s current price would drop -525.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -525.0% for stock’s current value.

In 2025, company’s earnings growth rate is likely to be around 50.60% while estimates for its earnings growth in next 5 years are of 21.38%.

Nektar Therapeutics (NASDAQ:NKTR)’s Major holders

DEEP TRACK CAPITAL, LP is the top institutional holder at NKTR for having 17.88 million shares of worth $22.17 million. And as of 2024-06-30, it was holding 8.5599 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 15.16 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.7823 of outstanding shares, having a total worth of $18.79 million.